is a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications. AMIC's focus is
on transitioning to full operations upon receipt of FDA clearance for its patented brachytherapy cancer products.
Any sufficiently advanced technology is indistinguishable from magic.
– English physicist and visionary author - Arthur C. Clarke